FIELD: medicine.
SUBSTANCE: invention concerns biochemistry and medicine. There is offered therapeutic application of yessotoxins as inhibitors of human tumour cell growth. The mechanism of action of yessotoxin (YTX) is associated with activation of cell phosphodiesterases and respectively with decreasing the content of cyclic adenosine monophosphate in cytosol. This cytotoxic effect of YTX with respect to tumour cells can be applied as a strategy to develop preparation effective in treating tumour processes.
EFFECT: inhibition of human hepatocellular carcinoma cell growth following introduction of YTX.
3 cl, 1 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING (THERAPY OF) COMPENSATED NON-SPECIFIC CHRONIC TONSILLITIS | 2012 |
|
RU2510749C1 |
| AGENT BASED ON ENAMINOHYDRAZONOTHIAZOLE DERIVATIVE OF USNIC ACID, HAVING ABILITY TO ENHANCE CYTOTOXIC, ANTICANCER AND ANTIMETASTATIC ACTION OF TOPOTECAN | 2024 |
|
RU2833910C1 |
| PLATELET AGGREGATION INHIBITOR SHOWING ANTIMETASTATIC EFFECT | 2001 |
|
RU2192857C1 |
| AGENT PREVENTING MAMMAL NORMAL CELL TRANSFORMATION IN MALIGNANT CELLS | 2010 |
|
RU2429839C1 |
| NEW STERICALLY HINDERED PHENOLS CONTAINING BENZOFUROXAN FRAGMENTS WITH ANTITUMOR ACTIVITY | 2022 |
|
RU2796810C1 |
| METHOD OF PREPARING PREPARATION FOR DIRECTED DELIVERY OF ANTITUMOR DRUG IN CANCER CELL | 1998 |
|
RU2139083C1 |
| METHOD OF FORMATION OF TUMOR GROWTH IN LUNGS OF EXPERIMENTAL ANIMALS | 2023 |
|
RU2810431C1 |
| ANTI-TUMOR AGENT BENZAMIDE | 2003 |
|
RU2257894C1 |
| METHOD FOR PREVENTION OF AGGRAVATED RECURRENT RHINOSINUSITIS | 2013 |
|
RU2562537C2 |
| METHOD OF TREATING MALIGNANT TUMORS | 2019 |
|
RU2738165C1 |
